Gallic Acid: A Potential Anti-Cancer Agent

Chin J Integr Med. 2022 Jul;28(7):661-671. doi: 10.1007/s11655-021-3345-2. Epub 2021 Nov 10.

Abstract

Cancer is one of the most devastating diseases worldwide and definitive therapeutics for treating cancer are not yet available despite extensive research efforts. The key challenges include limiting factors connected with traditional chemotherapeutics, primarily drug resistance, low response rates, and adverse side-effects. Therefore, there is a high demand for novel anti-cancer drugs that are both potent and safe for cancer prevention and treatment. Gallic acid (GA), a natural botanic phenolic compound, can mediate various therapeutic properties that are involved in anti-inflammation, anti-obesity, and anti-cancer activities. More recently, GA has been shown to exert anti-cancer activities via several biological pathways that include migration, metastasis, apoptosis, cell cycle arrest, angiogenesis, and oncogene expression. This review discusses two aspects, one is the anti-cancer potential of GA against different types of cancer and the underlying molecular mechanisms, the other is the bibliometric analysis of GA in cancer and tumor research. The results indicated that lung cancer, prostate cancer, stomach cancer, and colon adenocarcinoma may become a hot topic in further research. Overall, this review provides evidence that GA represents a promising novel, potent, and safe anti-cancer drug candidate for treating cancer.

Keywords: application; bibliometric; cancer; gallic acid; tumor.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / drug therapy
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Apoptosis
  • Cell Line, Tumor
  • Colonic Neoplasms*
  • Gallic Acid / pharmacology
  • Gallic Acid / therapeutic use
  • Humans
  • Male

Substances

  • Antineoplastic Agents
  • Gallic Acid